A new Coronavirus strain, named SARS-CoV-2, suddenly emerged in early December\n2019. SARS-CoV-2 resulted in being dramatically infectious, with thousands of people infected. In\nthis scenario, and without effective vaccines available, the importance of an immediate tool to\nsupport patients and against viral diffusion becomes evident. In this study, we exploit the molecular\ndocking approach to analyze the affinity between different viral proteins and several inhibitors,\noriginally developed for other viral infections. Our data show that, in some cases, a relevant binding\ncan be detected. These findings support the hypothesis to develop new antiviral agents against\nCOVID-19, on the basis of already established therapies
Loading....